n
the interview below, Prof. Dr. Jörg Hacker, the Editor-in-Chief
of the International Journal of Medical Microbiology,
talks with in-cites about the journal’s history and citation
record. According to a recent analysis of
Essential Science Indicators ,
the International Journal of Medical Microbiology is in
the front half of journals in the field of Microbiology, and was
selected as a
New
Entrant in this field in June 2007. Its
current citation record includes 553 highly cited papers with a
total of 3,810 citations. Formerly published as Zentralblatt
für Bakteriologie, the International Journal of Medical
Microbiology is published by Elsevier. In addition to
his editorial responsibilities, Prof. Dr. Hacker is the Vice
President of the Deutsche Forschungsgemeinschaft, in Bonn,
Germany. |
Did you expect the International
Journal of Medical Microbiology to become highly cited, or is
this surprising to you?
The International Journal of Medical Microbiology has
developed in a rather successful way over the last few years. As
the Journal Citation Reports® impact factor was down to
0.5, it is not so surprising for me that it become higher in the
last few years. The International Journal of Medical
Microbiology has a very strong tradition, as the former
journal Zentralblatt für Bakteriologie represented one of
the top journals in the beginning of the 20th
century. Therefore, authors recognize this journal as an
interesting forum to publish their data. On the other hand, I am
quite surprised that we are not far away from an impact factor
of 3. This was not really expected at the beginning.
How would you account for the increased citation rate of the
International Journal of Medical Microbiology?
|
 |
|
|
“In our journal, we would like to publish
important articles that reflect the future of the medical
microbiology field.” |
|
|
We changed the strategy and the policy of the journal. First,
we focused the journal from a rather broad scope to a more
specific area on bacteriology and parasitology, as well as
mycology. In addition we published a number of interesting
special issues whose articles are highly cited. These special
issues cover exciting topics in medical microbiology. The
authors are carefully selected and I feel they recognize that it
is an honor to become invited for a review in our journal.
Thirdly, we also publish mini-reviews in the majority of the
"normal" issues. Furthermore, we always ask for three reviewers,
therefore we have a rejection rate of more than 70%. And last
but not least, we introduced the English language into all of
our correspondence, papers, and abstracts, turning the journal
into a really "international" one.
Was there a change in policy or editorial direction that might
account for this?
Aside from the aforementioned change in the focus of the
journal, we included a truly international board and highly
recognized co-editors into the group responsible for the
journal. In addition, we try to make fast decisions.
What historical factors have contributed to the success of the
International Journal of Medical Microbiology?
The journal has a very strong tradition. We try to mirror
this tradition with a number of historical articles composed by
leading scientists, who have a rather broad overview on their
field of microbiology.
Have there been specific developments in the fields served by the
International Journal of Medical Microbiology that may have
contributed?
Nowadays, medical microbiology is strongly associated with
genomics, cell biology, and molecular biology in general. As
already mentioned, we published different special issues that
cover these important and exciting fields—in particular, the
field of genomics strongly influences the editorial policy.
Furthermore, groups that belong to the leading teams in cellular
microbiology publish their papers in our journal.
What, in your view, is this journal’s main significance or
contribution in the field of Microbiology?
The International Journal of Medical Microbiology,
from my viewpoint, represents a rather broad forum for medical
microbiology in various sub-disciplines that, with the help of
editorials, seems to be interesting to the scientific community.
How do you see your field(s) evolving in the next few years?
From my viewpoint the main scientific avenues will continue.
Thus, DNA sequencing techniques will be more and more important
for molecular epidemiology of infectious diseases. In addition,
sequencing of host genes and their relation to resistance or
susceptibility to infectious diseases will become more
interesting. Furthermore, cell biology will cover more topics in
medical microbiology.
What role do you see for your journal?
In our journal, we would like to publish important articles
that reflect the future of the medical microbiology field. We
will further invite top scientists as guest editors for specific
issues. Furthermore, the mini-reviews will remain as significant
contributions to the development of our journal.
Prof. Dr. Jörg Hacker, Editor-in-Chief
International Journal of Medical Microbiology
Elsevier, publishers
| International Journal of Medical Microbiology's
most-cited paper with 11 cites to date: |
|
Diggle SP,
et al., "4-quinolone signalling in Pseudomonas
aeruginosa: old molecules, new perspectives," Int. J.
Med. Microbiol. 296(2-3): 83-91, April 2006. |
|
Source:
Essential Science Indicators |
|
|